Head-to-head · WeighScore
Fitness RX vs Omada Health
The verdict
Fitness RX takes it — 76.7/100 to 55.6/100.
Fitness RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fitness RX (fitnessrx.com) is a GLP-1 weight-loss program that bundles medication with fitness and nutrition coaching across a three-phase plan.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Fitness RX | Omada Health |
|---|---|---|
| WeighScore | 76.7/100 | 55.6/100 |
| Grade | C | C |
| Scorecard rank | #50 | #435 |
| Semaglutide | $119/mo (promotional rate, compounded) | Not disclosed |
| Tirzepatide | $119/mo (promotional rate, compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #50 · C
Strengths
- $119/mo all-in including medication, 1:1 physician consults, and unlimited messaging ($100-off-for-life intro promo)
- Both compounded (injectable + sublingual semaglutide/tirzepatide) and brand GLP-1 (Wegovy, Zepbound)
- Integrated fitness and nutrition/behavioral coaching (linked to the BodyFX brand)
- Publishes Terms, Privacy, and data-privacy policies; links to LegitScript verification
Where it loses points
- Promo-driven landing page; compounding pharmacy and legal entity not named
- Tirzepatide and brand pricing may differ from the advertised $119/mo plan
- LegitScript status links to a CAPTCHA-gated checker — not independently confirmed here
- Exact drug and dose are shown only after the intake quiz
Graded #435 · C
Strengths
- Added GLP-1 prescribing and medication management in late 2025
- Clinicians trained in obesity care, available in all 50 states
- Behavioral support wrapped before, during and after treatment
- GLP-1 Flex Care adds a cash-pay medication pathway in 2026
- Publicly traded, evidence-based virtual care platform
Where it loses points
- Core program distributed via employers and health plans, limited cash-pay
- GLP-1 prescribing is a recent addition still scaling
- GLP-1 Flex Care only rolling out to employers later in 2026
- No transparent published price for the core member program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.